Stay updated on IL-15 Combo with Nivolumab & Ipilimumab in Refractory Cancers Clinical Trial

Sign up to get notified when there's something new on the IL-15 Combo with Nivolumab & Ipilimumab in Refractory Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IL-15 Combo with Nivolumab & Ipilimumab in Refractory Cancers Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The record history adds a 'Results Posted' entry and updates multiple results-related sections (Outcome Measures, Adverse Events, Baseline Characteristics, Participant Flow, IPD Sharing, Study Description/Design) with a new version dated 2025-11-14, replacing the previous 'Results Submitted' entry.
    Difference
    0.6%
    Check dated 2025-12-08T23:56:04.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The page history shows a new revision v3.3.2 added and the previous revision v3.3.1 removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T17:51:26.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The latest version adds a 'Results Submitted' entry and removes 'No Results Posted' in the History. It is labeled Revision: v3.3.1.
    Difference
    0.1%
    Check dated 2025-11-24T14:57:15.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Removed a site-wide operating-status notice about government funding and NIH/Clinical Center status (including links to cc.nih.gov and opm.gov). The notice previously appeared at the top of the page.
    Difference
    0.2%
    Check dated 2025-11-17T07:16:41.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The page history shows a long series of version updates with repeated Study Status changes spanning 2018 to 2025, along with occasional edits to the study description, eligibility criteria, and outcome measures.
    Difference
    0.0%
    Check dated 2025-11-03T01:26:47.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Key updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.
    Difference
    7%
    Check dated 2025-10-05T10:38:35.000Z thumbnail image

Stay in the know with updates to IL-15 Combo with Nivolumab & Ipilimumab in Refractory Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IL-15 Combo with Nivolumab & Ipilimumab in Refractory Cancers Clinical Trial page.